The influence of volume ratio of ultrafiltrate of sample on the analysis of non-protein binding drugs in human plasma
Authors:
- 8 October 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 138 (24) , 7369-7375
Abstract
In human plasma, the total concentration of non-protein binding (NPB) drugs is equal to the free drug concentration because NPB drugs do not or hardly bind to plasma proteins. Thus, centrifuge ultrafiltration (CF-UF) has been used in the determination of the concentration of NPB drugs in human plasma. However, with only a common centrifugation, the recovery and the reproducibility were not as excellent as expected. In addition, we discovered that the values of the volume ratio of ultrafiltrate to sample solution (Vu/Vs) were different and could not be well controlled, which may affect the determination of the drug concentration. The problem also affected the determination of other NBP drugs. In the present work, we used biapenem as a representative drug to study the effect of Vu/Vs on the analysis of NPB drugs concentration in human plasma. The results showed that a Vu/Vs value of less than 0.4 had no effect on the analysis of free drug concentration, while a Vu/Vs value of more than 0.4 was associated with increased recovery rate and overestimation of drug concentration. Therefore, to maintain a Vu/Vs value of less than 0.4 and even at a constant value is the key to accurately determine the concentration of NPB drugs in plasma. Fortunately, with an HFCF-UF device, the Vu/Vs could be well controlled and kept at 0.08 in this study. The recovery rates were almost 100% and the analysis precision was greatly improved. In pharmacokinetics studies, this method was successfully employed to determine the concentration of biapenem with excellent accuracy and reproducibility. HFCF-UF may become a feasible platform for the determination of NPB drugs.Keywords
This publication has 18 references indexed in Scilit:
- Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration methodJournal of Chromatography B, 2012
- A Simple Sample Preparation Method for Measuring Amoxicillin in Human Plasma by Hollow Fiber Centrifugal UltrafiltrationJournal of Chromatographic Science, 2012
- Compilation of 222 drugs’ plasma protein binding data and guidance for study designsDrug Discovery Today, 2012
- Developing a robust ultrafiltration-LC–MS/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasmaJournal of Chromatography B, 2011
- Pretreatment of plasma samples by a novel hollow fiber centrifugal ultrafiltrate device for the determination of cefaclor concentrations in human plasmaJournal of Chromatography A, 2010
- Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infectionsInternational Journal of Antimicrobial Agents, 2009
- Quantification of doripenem in human plasma and peritoneal fluid by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B, 2008
- High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasmaJournal of Chromatography B, 2007
- A simple and rapid determination of biapenem in plasma by high-performance liquid chromatographyJournal of Chromatography B, 2006
- Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionizationJournal of Chromatography B, 2006